Biotechnology Technology Articles & Analysis
6 articles found
This article analyzes each aspect.DefinitionsSMDC consists of a small molecule drug (usually a highly active chemotherapy drug) and a targeting ligand (usually a small molecule), connected through conjugation technology. This conjugate can selectively deliver the drug to disease-related cells, such as cancer cells, thereby increasing efficacy and reducing toxicity to normal ...
Medical research indicates that nearly 93% of children in America suffer at least one middle ear infection, which is severe enough to see a doctor. Most will suffer repeat occurrences, up to a dozen or more in childhood. These painful episodes are difficult for children, parents, and caregivers. Accurate diagnosis of middle ear infections (Otitis Media) in infants and young children may be ...
This article estimates the production technical efficiency of pharmaceutical companies and biotechnology companies under heterogeneous technologies. We employ metafrontier analysis to estimate the production metafrontier technical efficiency during the period 1989–2007. ...
This paper examines how Europe's large chemical/pharmaceutical multinationals have developed their interests and capabilities in biotechnology and in particular the degree to which, in the process, they have become increasingly linked into the US science base. It looks at both direct linkages via subsidiary laboratories located on US soil and at indirect linkages via the small, ...
The study analyses the forces driving the change and the enabling factors that facilitate the response of various firms in the pharmaceutical industry, leading to consolidation and restructuring of the industry. A number of new technology platforms are emerging that are facilitating this change process. ...
Tracing the evolution of this industry, the paper first shows that Indian firms over the years had invested in gaining knowledge of the chemical technology of creating bulk drugs, and the top tier firms had greatly "learnt by doing", improving upon the process technology and bringing down their prices without investing in "formal R&D centers". ...